News & Media

Admedus HSV-2 clinical results encouraging – Morgans

7, March, 2016

Posted In: In the media, Uncategorized

Morgans healthcare analyst Scott Power talks to The Australian about Admedus’s HSV-2 Phase II clinical trial results.

Click here to read the full article.